1-4 of 4
Jonathan Heyen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB210: Preclinical development and evaluation of allogeneic CAR T cells targeting CD70 for the treatment of renal cell carcinoma

Siler Panowski, Surabhi Srinivasan, Nguyen Tan, Silvia Tacheva-Grigorova, Bryan Smith, Yvonne Mak, Hongxiu Ning, Jonathan Villanueva, Dinali Wijewarnasuriya, Shanshan Lang, Zea Melton, Adit Ghosh, Mathilde Dusseaux, Roman Galetto, Jonathan Heyen, Tao Sai, Thomas Van Blarcom, Javier Chaparro-Riggers, Barbra Sasu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB210.
DOI: https://doi.org/10.1158/1538-7445.AM2022-LB210
Published: 15 June 2022
View article
Journal Articles

Abstract 2326: Allo CAR T TM targeting CD70 for the treatment of renal cell carcinoma

Siler Panowski, Surabhi Srinivasan, Silvia Tacheva-Grigorova, Nguyen Tan, Thomas Van Blarcom, Tao Sai, Jonathan Heyen, Niranjana Nagarajan, Mathilde Dusseaux, Roman Galetto, Barbra Sasu
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2326.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2326
Published: 01 July 2019
View article
Journal Articles

Evaluation of blood pressure and cardiac structure and function following treatment with sunitinib in rats

Eileen Blasi, Jonathan Heyen, Shem Patyna, Michelle Hemkens, David Ramirez, Karen Wilkinson, Aileen McHarg
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4761.
Published: 01 May 2008
View article
Journal Articles

Modification of sunitinib malate (SU11248) blood pressure changes in rats

Eileen Blasi, Jill Steidl, Shem Patyna, Jonathan Heyen, Michelle Hemkens, Geoffrey Peng, Aileen McHarg
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1559.
Published: 01 May 2007
View article